haloperidol has been researched along with Cushing Syndrome in 2 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " No alpha-MSH could be detected in plasma of normal subjects (n = 6), in plasma of patients with Addison's disease (n = 3), Nelson's syndrome (n = 2), bromocriptine responsive (n = 2) and unresponsive (n = 5) Cushing's disease and in plasma of psychiatric patients on chronic treatment with the dopamine antagonist haloperidol (n = 5)." | 3.68 | Absence of detectable immunoreactive alpha melanocyte stimulating hormone in plasma in various types of Cushing's disease. ( Croughs, RJ; Mol, JA; Thijssen, JH, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Croughs, RJ | 1 |
| Thijssen, JH | 1 |
| Mol, JA | 1 |
| Yamaji, T | 1 |
| Ishibashi, M | 1 |
| Teramoto, A | 1 |
| Fukushima, T | 1 |
2 other studies available for haloperidol and Cushing Syndrome
| Article | Year |
|---|---|
Absence of detectable immunoreactive alpha melanocyte stimulating hormone in plasma in various types of Cushing's disease.
Topics: Addison Disease; Adrenocorticotropic Hormone; alpha-MSH; Animals; Cushing Syndrome; Dogs; Haloperido | 1991 |
Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Cells, Cultured; Corticotropin-Releasing Hormone; Cushi | 1985 |